The new screening test is a laboratory-developed test or LDT, so it does not require approval by the US Food and Drug Administration to be performed. Labcorp is in talks with health insurance ...

The US Food and Drug Administration (FDA) has approved Labcorp’s nAbCyte Anti-AAVRh74var ... A negative nAbCyte test indicates that an individual with moderate to severe haemophilia B can ...

Labcorp, a lab services company based in North Carolina, today announced that the US Food and Drug Administration (FDA) has granted emergency use authorization (EUA) for its PCR Test Home Collection ...

Patients wanting easy access to their lab test results from LabCorp can now get them through their smart phones. The Burlington-based diagnostics and drug-development company said it has begun ...

Burlington-based LabCorp has received approval from the U.S. Food and Drug Administration to market ... NGI is a specialty testing group that helps the global plasma industry screen for infectious ...

(RTTNews) - Labcorp Holdings Inc. (LH), Tuesday announced the launch of H5 bird flu molecular test in the U.S., except the New York state, to detect the potential cases of bird flu in humans.

New test supports public health preparedness efforts and testing infrastructure amid multistate outbreak of H5 bird flu in poultry and dairy cows BURLINGTON, N.C., Dec. 17, 2024 /PRNewswire ...